Serum albumin is superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1169-1173

  Fujii, Takaaki ^a   Sutoh, Toshinaga ^a   Morita, Hiroki ^a   Katoh, Toshihide ^a   Yajima, Reina ^a   Tsutsumi, Soichi ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PREALBUMIN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; RECTUM RESECTION; RECURRENCE RISK;

AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NUTRITIONAL STATUS; PREALBUMIN; RISK FACTORS; SERUM ALBUMIN;

EID: 84873616087     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.718034     Document Type: Article

References (36)

1. Ho SY, Guo HR, Chen HH, and Peng CJ: Nutritional predictors of survival in terminally ill cancer patients. J Formos Med Assoc 102, 544-550, 2003.
2. Dewy WD, Begg C, Lavin PT, Band PR, Bennett JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491-497, 1980.
3. Gupta D and Lis CG: Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J 9, 69, 2010.
4. Mclntosh EN and Laurent LL: Nutritional assessment of the hospitalized patient. Am Fam Physician 27, 169-175, 1983.
5. Delmore G: Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 5, 376-380, 1997.
6. Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, et al.: Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem 52, 2281-2285, 2006.
7. Beck FK and Rosenthal TC: Prealbumin: amarker for nutritional evaluation. Am Fam Physician 65, 1575-1578, 2002.
8. Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106-110, 1999.
9. MaMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, et al.: Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39, 210-213, 2001.
10. Walsh D, Mahmoud F, and Barna B: Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 11, 60-62, 2003.
11. Siddiqui A, Heinzerling J, Livingston EH, and Huerta S: Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 194, 362-366, 2007.
12. Boonpipattanapong T and Chewatanakornkul S: Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol 40, 592-595, 2006.
13. Lai CC, You JF, Yeh CY, Chen JS, Tang R, et al.: Low preoperative serum albmin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis 26, 473-481, 2011.
14. Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, et al.: Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 59, 923-928, 2011.
15. Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, et al.: Serum albumin as a significant prognositic factor for patients with gastric carcinoma. Ann Surg Oncol 14, 381-389, 2007.
16. Lis CG, Grutsch JF, Vashi PG, and Lammersfeld CA: Is albumin an independent predictor of survival in patients with breast cancer? J Parenter Enteral Nutr 27, 10-15, 2003.
17. Shimizu-Fujiwara M, Komaki H, Nakagawa E, Mori-Yoshimura M, Oya Y, et al.: Decreased resting energy expenditure in patients with Duchenne muscular dystrophy. Brain Dev 34, 206-212, 2011.
18. Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, et al.: Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 59, 923-928, 2011.
19. von Meyenfeldt M: Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs 9(Suppl. 2), S35-S28, 2005.
20. Mahlck CG and Grankvist K: Plasma prealbumin in women with epithelial ovarian carcinoma. Gynecol Obstet Invest 37, 135-140, 1994.
21. Milao G, Cooper EH, Goligher JC, Giles GR, and Neville AM: Serum prealbumin, retinol-binding protein, transferrin, and albumin levels in patients with large bowel cancer. J Natl Cancer Inst 61, 687-691.
22. Inoue Y, Nezu R, Matsuda H, Takagi Y, and Okada A: Rapid turnover proteins as a prognostic indicator in cancer patients. Surg Today 25, 498-506, 1995.
23. Mehta RR, Hart G, Beattie CW, and Das Gupta TK: Significance of plasma retinol binding protein levels in recurrence of breast tumors in women. Oncology 44, 350-355, 1987.
24. Roxburgh CS and McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6, 149-163, 2010.
25. Ishizuka M, Nagata H, Takagi K, Horie T, and Kubota K: Inflammationbased prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246, 1047-1051, 2007.
26. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, et al.: The relationship between tumor T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92, 651-654, 2005.
27. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 375, 539-545, 2001.
28. Kotler DP: Cachexia. Ann Intern Med 133, 622-634, 2000.
29. Rambod M, Kovesdy CP, Bross R, Koppele JD, and Kalantar-Zadeh K: Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 88, 1485-1494, 2008.
30. Fuhrman MP: The albumin-butrition connection: separatingmyth from fact. Nutrition 18, 199-200, 2002.
31. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, et al.: Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. J Parenter Enteral Nutr 8, 153-159, 1984.
32. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, et al.: Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41, 64-69, 2001.
33. Ishizuka M, Nagata H, Takagi K, Horie T, and Kubota K: Inflammationbased prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246, 1047-1051, 2007.
34. McMillan DC, Crozier JEM, Canna K, Angerson WJ, and McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22, 881-886, 2007.
35. Fujii T, Tabe Y, Yajima R, Yamaguchi S, Tsutsumi S, et al.: Elevated C-reactive protein level is associated with the tumor depth of invasion in patients with operable colorectal carcinoma. Hepatogastroenterology 58,1470-1473, 2011.
36. Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, et al.: Diseasefree survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23, 8664-8670, 2005.